Alsys

Alsys Research (also known as Alsyslife) is an integrated global biopharmaceutical company focused on the discovery and development of first-in-class and best-in-class natural product therapies for autoimmune and inflammatory skin disorders. The company leverages a proprietary drug discovery platform to target challenging pathways in dermatology, specifically focusing on conditions such as psoriasis, eczema, and atopic dermatitis. Its lead clinical candidates, PRC0028 and BA01, are developed as adenosine monophosphate (AMP) inhibitors, representing a novel approach to managing chronic skin inflammation. Headquartered in Switzerland with research facilities in India and the United States, Alsys Research aims to address significant unmet medical needs through innovative phytopharmaceutical science.